Skip to main content

Find Clinical Trials

Home
Conditions
Hypersensitivity

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,753 public trials 646 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.

NCT00600171

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Fresno, California, United States

GSK Investigational Site Huntington Beach, California, United States

View all 89 locations

View Trial Details

Completed

A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma

NCT00441441

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Huntington Beach, California, United States

GSK Investigational Site Long Beach, California, United States

GSK Investigational Site Long Beach, California, United States

GSK Investigational Site Riverside, California, United States

View all 55 locations

View Trial Details

Completed

A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis

NCT00609674

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: GSK Investigational Site Baltimore, Maryland, United States

GSK Investigational Site Wheaton, Maryland, United States

GSK Investigational Site North Dartmouth, Massachusetts, United States

GSK Investigational Site Minneapolis, Minnesota, United States

View all 37 locations

View Trial Details

Completed

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

NCT01444430

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Huntsville, Alabama, United States

Research Site Anchorage, Alaska, United States

Research Site Gilbert, Arizona, United States

View all 340 locations

View Trial Details

Completed

A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.

NCT01928368

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Research Site Cypress, California, United States

Research Site Aventura, Florida, United States

Research Site Lenexa, Kansas, United States

Research Site Raleigh, North Carolina, United States

View Trial Details

Completed

Expansion of the COPD At-risk Module in 4 States BRFSS Telephone Health Surveys

NCT02991391

Conditions: Air Quality, Asthma, Behavior, +19 more
Locations: Not specified

View Trial Details

Completed

A Call Center During HAE Attacks (SOS HAE)

NCT01679912

Conditions: Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations: SAMU 93 - Hôpital Avicenne Bobigny, Île-de-France Region, France

View Trial Details

Completed

Trial of Antimycobacterial Therapy in Sarcoidosis

NCT01074554

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
Locations: Vanderbilt University School of Medicine Nashville, Tennessee, United States

View Trial Details

Completed

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

NCT00519636

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Long Beach, California, United States

GSK Investigational Site Los Angeles, California, United States

View all 28 locations

View Trial Details

Completed

Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS

NCT00539006

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: GSK Investigational Site Scottsdale, Arizona, United States

GSK Investigational Site Fresno, California, United States

GSK Investigational Site Huntington Beach, California, United States

GSK Investigational Site Long Beach, California, United States

View all 24 locations

View Trial Details